Vilin Bio Med Limited (NSE:VILINBIO)

Market Cap	625.66M +113.6%
Revenue (ttm)	199.81M +52.7%
Net Income	2.51M
EPS	0.18
Shares Out	13.95M
PE Ratio	249.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,000
Average Volume	12,200
Open	44.85
Previous Close	42.75
Day's Range	44.80 - 44.85
52-Week Range	18.95 - 44.85
Beta	0.49
RSI	78.53
Earnings Date	May 15, 2026

About Vilin Bio Med

Vilin Bio Med Limited engages in the manufacture and trade of pharmaceutical products in India. It provides cardiovascular, musculo-skeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system and anti-allergic, anti- diabetic, liquid orals, and miscellaneous drugs, as well as multi-vitamins, minerals, and amino acids supplements. The company offers its products in the form of oral liquids, dry syrups, sachets, external preparations, beta and non beta lactam tablets and capsules, and nutritional food...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2005
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VILINBIO

Financial Performance

In fiscal year 2025, Vilin Bio Med's revenue was 148.10 million, a decrease of -6.30% compared to the previous year's 158.05 million. Earnings were 2.24 million, an increase of 37.62%.